Figure 6From: Nafamostat mesylate, a serine protease inhibitor, demonstrates novel antimicrobial properties and effectiveness in Chlamydia-induced arthritisComparison of Chlamydia recovery from synovial tissues of NM-treated and control knees, as assayed by ELISA. There is significantly more chlamydia in the synovial tissues of the non-treated control knees than in the NM treated ones (P = 0.003). ELISA, enzyme-linked immunosorbent assay; NM, nafamostat mesylate.Back to article page